1 commercial payer policy lists D57.21. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
1 policy from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D57.21 |
|---|---|---|
| Adakveo (Crizanlizumab-Tmca) | May 1, 2026 | Covered |